ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00130195
Recruitment Status : Completed
First Posted : August 15, 2005
Last Update Posted : November 14, 2008
Sponsor:
Information provided by:
Japan Adult Leukemia Study Group

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2008
  Actual Study Completion Date : May 2008
Publications of Results: